Z-1496-2018 Class II Terminated

Recalled by Diagnostic Hybrids, Inc. — Athens, OH

FDA device recall Z-1496-2018 was initiated by Diagnostic Hybrids, Inc. on Apr 4, 2017 and is designated Class II. Reason for recall: There is a potential for the slope of the standard curve to fail to meet the assay validation requirements for the assay. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 101 kits.

Recall details

Product Type
Devices
Report Date
May 2, 2018
Initiation Date
Apr 4, 2017
Termination Date
Aug 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101 kits

Product description

MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating immune complexes in human serum or plasma. The assay uses highly pure, functional human C1q coated in the solid phase to capture immune complexes (CIC). In the first stage, CIC in the diluted patient samples and HAGG in the controls and standards are dispensed into the C1q coated assay wells. After incubation, unbound material is removed in a washing step and a ready to use conjugate (goat anti-human Ig-HRP) is added. After a second incubation, unbound conjugate is washed away. After addition of a substrate and a short incubation interval, the quantity of CIC in the sample (¿g Eq/ml) can be determined by comparison to a standard curve.

Reason for recall

There is a potential for the slope of the standard curve to fail to meet the assay validation requirements for the assay.

Distribution pattern

The products were distributed to the following US states: NY, TX, CO, UT. The products were distributed to the following foreign countries: Switzerland.

Code information

Lot 084007

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1496-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1496-2018. Report a data issue: hello@regdatalab.com.